| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 75 | 2018 | 375 | 5.810 |
Why?
|
| Pneumococcal Infections | 59 | 2018 | 275 | 5.280 |
Why?
|
| Staphylococcal Infections | 52 | 2023 | 561 | 4.410 |
Why?
|
| Staphylococcus aureus | 41 | 2023 | 462 | 3.290 |
Why?
|
| Pneumococcal Vaccines | 33 | 2018 | 169 | 2.850 |
Why?
|
| Anti-Bacterial Agents | 58 | 2018 | 2431 | 1.820 |
Why?
|
| Community-Acquired Infections | 27 | 2018 | 241 | 1.820 |
Why?
|
| Microbial Sensitivity Tests | 60 | 2018 | 797 | 1.730 |
Why?
|
| Bacteremia | 28 | 2023 | 406 | 1.600 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 17 | 2018 | 222 | 1.380 |
Why?
|
| Penicillin Resistance | 30 | 2005 | 81 | 1.330 |
Why?
|
| Serotyping | 40 | 2018 | 178 | 1.080 |
Why?
|
| Infant | 120 | 2018 | 12515 | 1.020 |
Why?
|
| Child, Preschool | 117 | 2018 | 14027 | 1.000 |
Why?
|
| Population Surveillance | 12 | 2018 | 389 | 0.980 |
Why?
|
| Haemophilus influenzae | 30 | 2011 | 130 | 0.950 |
Why?
|
| Hospitals, Pediatric | 14 | 2018 | 763 | 0.880 |
Why?
|
| Osteomyelitis | 12 | 2017 | 207 | 0.870 |
Why?
|
| Mupirocin | 3 | 2015 | 19 | 0.840 |
Why?
|
| Child | 120 | 2018 | 24424 | 0.750 |
Why?
|
| Vaccines, Conjugate | 12 | 2018 | 78 | 0.700 |
Why?
|
| Vancomycin | 11 | 2017 | 220 | 0.650 |
Why?
|
| Pneumonia, Pneumococcal | 9 | 2017 | 83 | 0.620 |
Why?
|
| Penicillins | 13 | 2016 | 154 | 0.610 |
Why?
|
| Meningitis, Pneumococcal | 11 | 2015 | 41 | 0.600 |
Why?
|
| Chlorhexidine | 3 | 2017 | 47 | 0.600 |
Why?
|
| Haemophilus Infections | 15 | 2003 | 91 | 0.580 |
Why?
|
| Otitis Media | 11 | 2015 | 85 | 0.580 |
Why?
|
| Methicillin Resistance | 17 | 2015 | 118 | 0.540 |
Why?
|
| Humans | 211 | 2023 | 125128 | 0.540 |
Why?
|
| Drug Resistance, Bacterial | 15 | 2017 | 365 | 0.500 |
Why?
|
| Adolescent | 66 | 2018 | 19361 | 0.500 |
Why?
|
| Infant, Newborn | 68 | 2018 | 8232 | 0.490 |
Why?
|
| Soft Tissue Infections | 6 | 2015 | 85 | 0.490 |
Why?
|
| Male | 111 | 2018 | 61501 | 0.490 |
Why?
|
| Empyema | 4 | 2010 | 24 | 0.480 |
Why?
|
| Female | 116 | 2018 | 66781 | 0.470 |
Why?
|
| Meningococcal Vaccines | 5 | 2006 | 30 | 0.460 |
Why?
|
| Carrier State | 6 | 2011 | 76 | 0.460 |
Why?
|
| Cross Infection | 11 | 2016 | 325 | 0.440 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2014 | 39 | 0.440 |
Why?
|
| Sodium Hypochlorite | 1 | 2013 | 7 | 0.440 |
Why?
|
| Streptococcal Infections | 8 | 2001 | 240 | 0.440 |
Why?
|
| Baths | 1 | 2013 | 16 | 0.440 |
Why?
|
| Disinfection | 1 | 2013 | 26 | 0.430 |
Why?
|
| Hygiene | 1 | 2013 | 27 | 0.430 |
Why?
|
| Disinfectants | 1 | 2013 | 25 | 0.430 |
Why?
|
| Serogroup | 7 | 2018 | 60 | 0.430 |
Why?
|
| Staphylococcal Skin Infections | 5 | 2014 | 40 | 0.400 |
Why?
|
| Texas | 24 | 2018 | 3588 | 0.400 |
Why?
|
| Meningococcal Infections | 3 | 2013 | 19 | 0.390 |
Why?
|
| Cephalosporins | 13 | 2002 | 137 | 0.380 |
Why?
|
| Bacterial Typing Techniques | 7 | 2011 | 102 | 0.370 |
Why?
|
| Utah | 11 | 2016 | 47 | 0.370 |
Why?
|
| Arthritis, Infectious | 4 | 2017 | 59 | 0.370 |
Why?
|
| Incidence | 26 | 2016 | 3146 | 0.370 |
Why?
|
| Mastoiditis | 3 | 2015 | 33 | 0.360 |
Why?
|
| Clindamycin | 7 | 2011 | 40 | 0.360 |
Why?
|
| Empyema, Pleural | 3 | 2011 | 25 | 0.360 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2017 | 71 | 0.350 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 10 | 2016 | 25 | 0.350 |
Why?
|
| Ampicillin | 11 | 1991 | 56 | 0.340 |
Why?
|
| Immunocompromised Host | 5 | 2016 | 294 | 0.340 |
Why?
|
| Ceftriaxone | 12 | 2016 | 67 | 0.320 |
Why?
|
| Nasopharynx | 2 | 2005 | 79 | 0.310 |
Why?
|
| Retrospective Studies | 40 | 2018 | 16348 | 0.300 |
Why?
|
| Prospective Studies | 33 | 2016 | 6150 | 0.300 |
Why?
|
| Cephalosporin Resistance | 5 | 2002 | 17 | 0.290 |
Why?
|
| Sinusitis | 4 | 2014 | 116 | 0.280 |
Why?
|
| Multilocus Sequence Typing | 5 | 2016 | 57 | 0.280 |
Why?
|
| Shigella dysenteriae | 2 | 1998 | 2 | 0.280 |
Why?
|
| Dysentery, Bacillary | 2 | 1998 | 10 | 0.280 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2016 | 133 | 0.280 |
Why?
|
| Meningitis, Haemophilus | 9 | 1995 | 34 | 0.270 |
Why?
|
| Meningitis, Bacterial | 6 | 2017 | 95 | 0.270 |
Why?
|
| Prevalence | 9 | 2018 | 2458 | 0.270 |
Why?
|
| United States | 26 | 2018 | 10891 | 0.260 |
Why?
|
| Chloramphenicol | 7 | 1991 | 28 | 0.260 |
Why?
|
| Genotype | 9 | 2018 | 2565 | 0.260 |
Why?
|
| Methicillin | 9 | 2010 | 43 | 0.260 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 10 | 2015 | 92 | 0.260 |
Why?
|
| Organ Transplantation | 3 | 2016 | 168 | 0.250 |
Why?
|
| Molecular Epidemiology | 6 | 2013 | 155 | 0.250 |
Why?
|
| Leukocidins | 7 | 2018 | 38 | 0.250 |
Why?
|
| Exotoxins | 7 | 2018 | 45 | 0.250 |
Why?
|
| Bacteriological Techniques | 4 | 2016 | 87 | 0.240 |
Why?
|
| England | 4 | 2023 | 59 | 0.240 |
Why?
|
| Pneumonia, Bacterial | 1 | 2006 | 77 | 0.240 |
Why?
|
| Immunization Schedule | 3 | 2016 | 102 | 0.230 |
Why?
|
| Cefotaxime | 6 | 2001 | 35 | 0.230 |
Why?
|
| Hospitals | 4 | 2023 | 391 | 0.230 |
Why?
|
| Drug Resistance, Microbial | 12 | 2000 | 194 | 0.230 |
Why?
|
| Meningitis | 8 | 1990 | 98 | 0.230 |
Why?
|
| Sepsis | 8 | 2005 | 481 | 0.220 |
Why?
|
| Cellulitis | 4 | 2011 | 62 | 0.220 |
Why?
|
| State Medicine | 1 | 2023 | 12 | 0.220 |
Why?
|
| Erythromycin | 2 | 2003 | 20 | 0.220 |
Why?
|
| DNA, Bacterial | 7 | 2010 | 478 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 10 | 2011 | 1586 | 0.210 |
Why?
|
| Drug Resistance, Multiple | 1 | 2003 | 48 | 0.210 |
Why?
|
| Chi-Square Distribution | 8 | 2013 | 589 | 0.210 |
Why?
|
| Licensure | 1 | 2003 | 14 | 0.210 |
Why?
|
| Ketolides | 1 | 2003 | 4 | 0.210 |
Why?
|
| Recurrence | 8 | 2016 | 1420 | 0.210 |
Why?
|
| Disease Outbreaks | 4 | 1998 | 320 | 0.200 |
Why?
|
| Measles | 3 | 1997 | 41 | 0.200 |
Why?
|
| DNA Fingerprinting | 5 | 2010 | 107 | 0.200 |
Why?
|
| Fimbriae, Bacterial | 7 | 1992 | 42 | 0.190 |
Why?
|
| Cluster Analysis | 4 | 2011 | 398 | 0.190 |
Why?
|
| Labyrinthitis | 3 | 1991 | 10 | 0.190 |
Why?
|
| Bacterial Infections | 7 | 2011 | 308 | 0.190 |
Why?
|
| Antibodies, Bacterial | 9 | 2003 | 389 | 0.190 |
Why?
|
| Bacterial Toxins | 7 | 2018 | 175 | 0.190 |
Why?
|
| Premedication | 2 | 1991 | 42 | 0.180 |
Why?
|
| Infant, Low Birth Weight | 5 | 1996 | 167 | 0.180 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2001 | 136 | 0.180 |
Why?
|
| Measles Vaccine | 2 | 1997 | 11 | 0.180 |
Why?
|
| Intestinal Perforation | 2 | 1991 | 56 | 0.170 |
Why?
|
| Ear, Middle | 2 | 2015 | 25 | 0.170 |
Why?
|
| Oxazoles | 2 | 1999 | 23 | 0.170 |
Why?
|
| Neutrophils | 8 | 2013 | 381 | 0.170 |
Why?
|
| HIV Infections | 1 | 2012 | 1899 | 0.170 |
Why?
|
| Oxazolidinones | 2 | 1999 | 33 | 0.170 |
Why?
|
| Adult | 25 | 2015 | 29611 | 0.160 |
Why?
|
| Acetamides | 2 | 1999 | 47 | 0.160 |
Why?
|
| Statistics, Nonparametric | 5 | 2013 | 435 | 0.160 |
Why?
|
| Appendicitis | 2 | 1991 | 128 | 0.160 |
Why?
|
| Dexamethasone | 4 | 1998 | 276 | 0.160 |
Why?
|
| Child, Hospitalized | 2 | 2002 | 72 | 0.160 |
Why?
|
| Leukocyte Count | 6 | 2013 | 250 | 0.150 |
Why?
|
| Orbital Cellulitis | 1 | 2018 | 14 | 0.150 |
Why?
|
| Arthritis | 1 | 1998 | 81 | 0.150 |
Why?
|
| Age Distribution | 6 | 2010 | 419 | 0.140 |
Why?
|
| Cerebral Ventriculitis | 1 | 2017 | 15 | 0.140 |
Why?
|
| Citrobacter | 5 | 1992 | 21 | 0.140 |
Why?
|
| Ceftizoxime | 1 | 1997 | 2 | 0.140 |
Why?
|
| Young Adult | 9 | 2015 | 9049 | 0.140 |
Why?
|
| Immunization, Secondary | 1 | 1997 | 104 | 0.140 |
Why?
|
| Drug Therapy, Combination | 11 | 1998 | 1172 | 0.140 |
Why?
|
| Vaccination | 6 | 2011 | 963 | 0.140 |
Why?
|
| Ticarcillin | 2 | 1991 | 8 | 0.130 |
Why?
|
| Patient Admission | 1 | 2018 | 184 | 0.130 |
Why?
|
| Treatment Outcome | 16 | 2018 | 12391 | 0.130 |
Why?
|
| Zimbabwe | 6 | 1998 | 10 | 0.130 |
Why?
|
| Hospitalization | 3 | 2017 | 1783 | 0.130 |
Why?
|
| Bacterial Adhesion | 4 | 1993 | 105 | 0.130 |
Why?
|
| Pandemics | 1 | 2023 | 1108 | 0.130 |
Why?
|
| Meningitis, Meningococcal | 3 | 2013 | 14 | 0.120 |
Why?
|
| Radiography, Interventional | 1 | 2016 | 86 | 0.120 |
Why?
|
| Bacteria | 2 | 1994 | 484 | 0.120 |
Why?
|
| Retropharyngeal Abscess | 1 | 2015 | 7 | 0.120 |
Why?
|
| Mastoid | 1 | 2015 | 24 | 0.120 |
Why?
|
| Risk Factors | 13 | 2012 | 10314 | 0.120 |
Why?
|
| Gentamicins | 2 | 1995 | 95 | 0.120 |
Why?
|
| Cephamycins | 7 | 1983 | 11 | 0.120 |
Why?
|
| Rats | 8 | 1991 | 3727 | 0.120 |
Why?
|
| Haemophilus Vaccines | 2 | 1992 | 30 | 0.120 |
Why?
|
| Bacterial Vaccines | 2 | 1992 | 99 | 0.110 |
Why?
|
| Diterpenes | 1 | 2014 | 28 | 0.110 |
Why?
|
| Deafness | 3 | 1998 | 82 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 1998 | 1025 | 0.110 |
Why?
|
| Nasal Cavity | 2 | 2011 | 50 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2013 | 238 | 0.100 |
Why?
|
| Acute Disease | 8 | 2012 | 1111 | 0.100 |
Why?
|
| Down Syndrome | 1 | 2015 | 198 | 0.100 |
Why?
|
| Rifampin | 4 | 1998 | 130 | 0.100 |
Why?
|
| Cerebral Ventricles | 2 | 1990 | 81 | 0.100 |
Why?
|
| Time Factors | 9 | 2015 | 6329 | 0.100 |
Why?
|
| Neisseria meningitidis | 3 | 2013 | 19 | 0.100 |
Why?
|
| Tetanus Toxoid | 1 | 1992 | 45 | 0.100 |
Why?
|
| Labyrinth Diseases | 2 | 1989 | 6 | 0.100 |
Why?
|
| Bacterial Proteins | 4 | 2013 | 890 | 0.100 |
Why?
|
| Fractures, Spontaneous | 1 | 2012 | 18 | 0.100 |
Why?
|
| Growth Plate | 1 | 2012 | 20 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 5 | 1982 | 171 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 2057 | 0.100 |
Why?
|
| Lung Diseases | 3 | 2005 | 384 | 0.090 |
Why?
|
| Immunization Programs | 3 | 2015 | 63 | 0.090 |
Why?
|
| Pentoxifylline | 1 | 1991 | 20 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 175 | 0.090 |
Why?
|
| Surgical Wound Infection | 2 | 1991 | 261 | 0.090 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2011 | 18 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 233 | 0.090 |
Why?
|
| Clavulanic Acids | 1 | 1991 | 2 | 0.090 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 1996 | 141 | 0.090 |
Why?
|
| Cefuroxime | 5 | 2001 | 15 | 0.090 |
Why?
|
| Anti-Infective Agents | 2 | 2015 | 265 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2012 | 203 | 0.090 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2010 | 35 | 0.080 |
Why?
|
| Age Factors | 5 | 2006 | 2823 | 0.080 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 1991 | 60 | 0.080 |
Why?
|
| Comorbidity | 5 | 2017 | 1534 | 0.080 |
Why?
|
| Middle Aged | 11 | 2015 | 26920 | 0.080 |
Why?
|
| Bronchodilator Agents | 1 | 1991 | 151 | 0.080 |
Why?
|
| Viral Load | 1 | 2012 | 387 | 0.080 |
Why?
|
| Sequence Homology | 1 | 2009 | 63 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 153 | 0.080 |
Why?
|
| Fever | 2 | 2000 | 299 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 1988 | 297 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2002 | 4395 | 0.080 |
Why?
|
| Oxacillin | 3 | 1995 | 6 | 0.080 |
Why?
|
| Erythrocytes | 1 | 1990 | 219 | 0.080 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2000 | 87 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 178 | 0.080 |
Why?
|
| Cochlea | 1 | 1989 | 86 | 0.080 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2009 | 43 | 0.080 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2008 | 3 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3573 | 0.080 |
Why?
|
| Encephalitis | 1 | 1990 | 111 | 0.080 |
Why?
|
| Aged | 7 | 2015 | 19870 | 0.080 |
Why?
|
| Moxalactam | 10 | 1988 | 21 | 0.070 |
Why?
|
| Catheter-Related Infections | 1 | 2010 | 129 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 1203 | 0.070 |
Why?
|
| Animals, Newborn | 6 | 1993 | 1017 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 110 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 1992 | 331 | 0.070 |
Why?
|
| Infant, Premature, Diseases | 4 | 1998 | 244 | 0.070 |
Why?
|
| Neoplasms | 2 | 2013 | 2790 | 0.070 |
Why?
|
| Arkansas | 2 | 2004 | 58 | 0.070 |
Why?
|
| Staphylococcus | 5 | 1994 | 69 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2012 | 3300 | 0.070 |
Why?
|
| Brain Abscess | 1 | 1988 | 50 | 0.070 |
Why?
|
| Polysaccharides, Bacterial | 5 | 2013 | 68 | 0.070 |
Why?
|
| Rats, Inbred Strains | 5 | 1991 | 233 | 0.070 |
Why?
|
| Culture Media | 4 | 1993 | 182 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 3 | 1996 | 256 | 0.060 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2006 | 14 | 0.060 |
Why?
|
| Myositis | 1 | 2006 | 62 | 0.060 |
Why?
|
| Streptococcus agalactiae | 5 | 1981 | 99 | 0.060 |
Why?
|
| beta-Lactams | 2 | 2004 | 51 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1755 | 0.060 |
Why?
|
| Infant, Premature | 4 | 2007 | 829 | 0.060 |
Why?
|
| Morbidity | 1 | 2006 | 249 | 0.060 |
Why?
|
| Virus Diseases | 2 | 2011 | 280 | 0.060 |
Why?
|
| Immunization | 2 | 2006 | 307 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2016 | 4811 | 0.060 |
Why?
|
| Peru | 1 | 2005 | 47 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 1992 | 396 | 0.060 |
Why?
|
| Length of Stay | 3 | 2018 | 1310 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2006 | 135 | 0.060 |
Why?
|
| Gastroplasty | 1 | 2005 | 11 | 0.060 |
Why?
|
| Pharynx | 3 | 1982 | 66 | 0.060 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2005 | 63 | 0.060 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 86 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 4 | 1989 | 107 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2004 | 341 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2010 | 662 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 183 | 0.060 |
Why?
|
| Azithromycin | 1 | 2004 | 43 | 0.050 |
Why?
|
| Virulence Factors | 2 | 2018 | 173 | 0.050 |
Why?
|
| Musculoskeletal Diseases | 1 | 2004 | 57 | 0.050 |
Why?
|
| Macrolides | 1 | 2003 | 29 | 0.050 |
Why?
|
| Urban Health | 3 | 1997 | 78 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2003 | 97 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 134 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 1996 | 473 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 1998 | 316 | 0.050 |
Why?
|
| Drug Administration Schedule | 4 | 2005 | 729 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 1983 | 94 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2003 | 184 | 0.050 |
Why?
|
| Animals | 15 | 2006 | 34235 | 0.050 |
Why?
|
| Staphylococcus epidermidis | 2 | 1993 | 39 | 0.050 |
Why?
|
| Bronchitis, Chronic | 1 | 2001 | 18 | 0.050 |
Why?
|
| Escherichia coli Infections | 4 | 1995 | 189 | 0.050 |
Why?
|
| Splenectomy | 1 | 2002 | 65 | 0.050 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2001 | 35 | 0.050 |
Why?
|
| Sex Distribution | 3 | 2010 | 308 | 0.050 |
Why?
|
| Virulence | 3 | 2005 | 264 | 0.050 |
Why?
|
| Birth Weight | 5 | 1996 | 345 | 0.050 |
Why?
|
| Candidiasis | 2 | 1996 | 129 | 0.050 |
Why?
|
| Rupture, Spontaneous | 2 | 1991 | 49 | 0.050 |
Why?
|
| Spleen | 1 | 2002 | 281 | 0.040 |
Why?
|
| Otitis Media with Effusion | 1 | 2001 | 18 | 0.040 |
Why?
|
| Facial Dermatoses | 1 | 2000 | 8 | 0.040 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2000 | 8 | 0.040 |
Why?
|
| Legionella | 1 | 1980 | 9 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2013 | 5176 | 0.040 |
Why?
|
| Ear, Inner | 2 | 1991 | 49 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1991 | 52 | 0.040 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 873 | 0.040 |
Why?
|
| Phenotype | 3 | 2003 | 4262 | 0.040 |
Why?
|
| Drug Synergism | 5 | 1998 | 228 | 0.040 |
Why?
|
| Streptococcus pyogenes | 2 | 2011 | 76 | 0.040 |
Why?
|
| Prognosis | 5 | 2013 | 4644 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 274 | 0.040 |
Why?
|
| Linezolid | 2 | 1999 | 25 | 0.040 |
Why?
|
| Pentosephosphates | 3 | 1992 | 9 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2001 | 218 | 0.040 |
Why?
|
| Kinetics | 8 | 1992 | 1333 | 0.040 |
Why?
|
| Immunoglobulin A | 2 | 1997 | 207 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2003 | 543 | 0.040 |
Why?
|
| Serratia Infections | 1 | 1998 | 4 | 0.040 |
Why?
|
| Serratia marcescens | 1 | 1998 | 10 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2002 | 1438 | 0.040 |
Why?
|
| Probability | 3 | 2005 | 320 | 0.040 |
Why?
|
| Milk, Human | 2 | 2001 | 300 | 0.040 |
Why?
|
| Cytomegalovirus Infections | 2 | 1980 | 221 | 0.040 |
Why?
|
| Flavobacterium | 1 | 1998 | 4 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2001 | 575 | 0.040 |
Why?
|
| Bilirubin | 1 | 1979 | 122 | 0.040 |
Why?
|
| Infection Control | 2 | 2015 | 156 | 0.040 |
Why?
|
| Food Preservation | 1 | 1997 | 4 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1991 | 1242 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1997 | 96 | 0.030 |
Why?
|
| Bacterial Capsules | 1 | 2016 | 37 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2014 | 1197 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 604 | 0.030 |
Why?
|
| Cholera | 1 | 1996 | 25 | 0.030 |
Why?
|
| Radiography | 1 | 1998 | 822 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 320 | 0.030 |
Why?
|
| Fetal Blood | 1 | 1976 | 176 | 0.030 |
Why?
|
| beta-Lactam Resistance | 1 | 1996 | 47 | 0.030 |
Why?
|
| Species Specificity | 3 | 1992 | 550 | 0.030 |
Why?
|
| Risk | 1 | 1997 | 756 | 0.030 |
Why?
|
| Adhesins, Bacterial | 2 | 2006 | 75 | 0.030 |
Why?
|
| Reference Standards | 1 | 1996 | 236 | 0.030 |
Why?
|
| Necrosis | 2 | 2008 | 208 | 0.030 |
Why?
|
| Administration, Oral | 2 | 1995 | 684 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1995 | 143 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2015 | 59 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2001 | 862 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 3423 | 0.030 |
Why?
|
| Pseudomonas Infections | 1 | 1995 | 114 | 0.030 |
Why?
|
| Base Sequence | 3 | 2007 | 3103 | 0.030 |
Why?
|
| Coagulase | 2 | 1994 | 23 | 0.030 |
Why?
|
| Epithelium | 3 | 1992 | 364 | 0.030 |
Why?
|
| Jejunoileal Bypass | 1 | 1993 | 4 | 0.030 |
Why?
|
| Amikacin | 2 | 1993 | 24 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2012 | 3465 | 0.030 |
Why?
|
| Gestational Age | 4 | 1996 | 1167 | 0.030 |
Why?
|
| Blood | 1 | 2014 | 104 | 0.030 |
Why?
|
| DNA Primers | 1 | 1995 | 657 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2010 | 2913 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 3892 | 0.030 |
Why?
|
| Eczema | 1 | 2013 | 29 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2013 | 30 | 0.030 |
Why?
|
| Obesity | 1 | 2005 | 2248 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 2885 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2001 | 1637 | 0.030 |
Why?
|
| Respirovirus Infections | 1 | 1993 | 19 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 2173 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2013 | 193 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 131 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 666 | 0.030 |
Why?
|
| Survival Rate | 4 | 2005 | 2062 | 0.030 |
Why?
|
| Endoscopy | 1 | 2014 | 281 | 0.020 |
Why?
|
| Cerebrospinal Fluid Proteins | 2 | 1990 | 23 | 0.020 |
Why?
|
| Glycemic Index | 1 | 2012 | 19 | 0.020 |
Why?
|
| Quinine | 1 | 2012 | 7 | 0.020 |
Why?
|
| Otitis | 1 | 2012 | 11 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1993 | 147 | 0.020 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 44 | 0.020 |
Why?
|
| Sputum | 2 | 2003 | 106 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 54 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2012 | 47 | 0.020 |
Why?
|
| Temporal Bone | 2 | 2008 | 36 | 0.020 |
Why?
|
| Cheek | 2 | 1989 | 27 | 0.020 |
Why?
|
| Opsonin Proteins | 2 | 2001 | 20 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2012 | 40 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2011 | 34 | 0.020 |
Why?
|
| Survival Analysis | 3 | 2005 | 1506 | 0.020 |
Why?
|
| Subdural Effusion | 1 | 1991 | 8 | 0.020 |
Why?
|
| Ampicillin Resistance | 1 | 1991 | 17 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2001 | 459 | 0.020 |
Why?
|
| Epiglottitis | 1 | 1991 | 12 | 0.020 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2011 | 12 | 0.020 |
Why?
|
| Cause of Death | 1 | 2013 | 476 | 0.020 |
Why?
|
| Hearing Loss, Bilateral | 1 | 1991 | 16 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2012 | 211 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1991 | 107 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 1989 | 983 | 0.020 |
Why?
|
| Phagocytosis | 4 | 2001 | 170 | 0.020 |
Why?
|
| Mice, Mutant Strains | 3 | 1996 | 384 | 0.020 |
Why?
|
| Osteoarthritis | 1 | 2012 | 86 | 0.020 |
Why?
|
| Erythrocyte Count | 1 | 1990 | 21 | 0.020 |
Why?
|
| Hemadsorption | 1 | 1990 | 3 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2012 | 367 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2011 | 230 | 0.020 |
Why?
|
| Appendectomy | 1 | 1991 | 86 | 0.020 |
Why?
|
| Bacteriophage Typing | 1 | 1989 | 2 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2009 | 15 | 0.020 |
Why?
|
| Polysaccharides | 2 | 1988 | 140 | 0.020 |
Why?
|
| Pleural Effusion | 2 | 2002 | 102 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 1990 | 89 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 527 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1990 | 156 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 696 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2003 | 777 | 0.020 |
Why?
|
| Gastric Bypass | 2 | 2005 | 71 | 0.020 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1989 | 53 | 0.020 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 1989 | 77 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1990 | 410 | 0.020 |
Why?
|
| Diphtheria Toxoid | 1 | 1988 | 7 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1991 | 510 | 0.020 |
Why?
|
| Monocytes | 1 | 1990 | 345 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 555 | 0.020 |
Why?
|
| Sex Factors | 2 | 2006 | 1287 | 0.020 |
Why?
|
| Leukocytosis | 2 | 2000 | 46 | 0.020 |
Why?
|
| Adhesiveness | 2 | 1985 | 12 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1990 | 797 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1988 | 132 | 0.020 |
Why?
|
| Contrast Media | 1 | 2012 | 480 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1985 | 387 | 0.020 |
Why?
|
| Genomic Islands | 1 | 2007 | 29 | 0.020 |
Why?
|
| Complement Pathway, Alternative | 1 | 1987 | 14 | 0.020 |
Why?
|
| Complement Activation | 1 | 1987 | 52 | 0.020 |
Why?
|
| Half-Life | 2 | 1985 | 158 | 0.020 |
Why?
|
| Critical Care | 1 | 2013 | 657 | 0.020 |
Why?
|
| Hydrolases | 1 | 2007 | 56 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 168 | 0.020 |
Why?
|
| Pneumonia | 1 | 1991 | 325 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2003 | 455 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 824 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 1987 | 47 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 211 | 0.020 |
Why?
|
| Amphotericin B | 1 | 1987 | 90 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 513 | 0.020 |
Why?
|
| Genetic Variation | 1 | 1993 | 1502 | 0.020 |
Why?
|
| Polymyxins | 1 | 1986 | 15 | 0.020 |
Why?
|
| Horses | 1 | 2006 | 90 | 0.020 |
Why?
|
| Endotoxins | 1 | 1986 | 48 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1988 | 1102 | 0.020 |
Why?
|
| Health | 1 | 2006 | 37 | 0.020 |
Why?
|
| Glucose | 1 | 1990 | 877 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1985 | 34 | 0.020 |
Why?
|
| Streptococcus | 2 | 1987 | 60 | 0.020 |
Why?
|
| Polymyxin B | 1 | 1986 | 47 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 1897 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 77 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2005 | 9 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 100 | 0.010 |
Why?
|
| Pregnancy | 6 | 2003 | 7208 | 0.010 |
Why?
|
| Electrophoresis | 2 | 1995 | 50 | 0.010 |
Why?
|
| Nasal Mucosa | 2 | 2001 | 66 | 0.010 |
Why?
|
| Clone Cells | 1 | 2005 | 166 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1988 | 985 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 816 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 359 | 0.010 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 2003 | 5 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 2003 | 6 | 0.010 |
Why?
|
| Hexosyltransferases | 1 | 2003 | 7 | 0.010 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2003 | 14 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1984 | 58 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 2107 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2006 | 178 | 0.010 |
Why?
|
| Demography | 1 | 2004 | 239 | 0.010 |
Why?
|
| Anuria | 1 | 1983 | 13 | 0.010 |
Why?
|
| Kidney | 2 | 1996 | 1368 | 0.010 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 1996 | 207 | 0.010 |
Why?
|
| Lung Abscess | 1 | 2002 | 14 | 0.010 |
Why?
|
| Umbilical Cord | 2 | 1980 | 56 | 0.010 |
Why?
|
| Nafcillin | 1 | 1982 | 14 | 0.010 |
Why?
|
| Viruses | 1 | 2003 | 122 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2001 | 23 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 595 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 718 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 1982 | 52 | 0.010 |
Why?
|
| Serologic Tests | 1 | 2002 | 118 | 0.010 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2001 | 120 | 0.010 |
Why?
|
| Ribotyping | 1 | 2001 | 50 | 0.010 |
Why?
|
| Penicillin G Procaine | 1 | 1981 | 2 | 0.010 |
Why?
|
| Penicillin G | 1 | 2001 | 19 | 0.010 |
Why?
|
| Safety | 1 | 2001 | 217 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2001 | 471 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2001 | 153 | 0.010 |
Why?
|
| Syphilis, Congenital | 1 | 1981 | 28 | 0.010 |
Why?
|
| Luminescent Measurements | 3 | 1987 | 59 | 0.010 |
Why?
|
| Medical Records | 1 | 2001 | 191 | 0.010 |
Why?
|
| Schools | 1 | 1982 | 219 | 0.010 |
Why?
|
| Causality | 1 | 2000 | 84 | 0.010 |
Why?
|
| NAD | 1 | 1980 | 45 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 93 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6597 | 0.010 |
Why?
|
| Mortality | 1 | 2002 | 238 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1980 | 81 | 0.010 |
Why?
|
| Charcoal | 1 | 1979 | 6 | 0.010 |
Why?
|
| Methods | 1 | 1979 | 149 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1979 | 60 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 1051 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2005 | 1565 | 0.010 |
Why?
|
| Vagina | 1 | 1980 | 185 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1022 | 0.010 |
Why?
|
| Models, Biological | 2 | 1993 | 1460 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 1238 | 0.010 |
Why?
|
| Refrigeration | 1 | 1997 | 9 | 0.010 |
Why?
|
| Freezing | 1 | 1997 | 28 | 0.010 |
Why?
|
| Food Contamination | 1 | 1997 | 23 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 1997 | 89 | 0.010 |
Why?
|
| Puerperal Infection | 1 | 1977 | 7 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 176 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1977 | 82 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1976 | 22 | 0.010 |
Why?
|
| Respiratory Tract Diseases | 1 | 1997 | 75 | 0.010 |
Why?
|
| Phagocytes | 1 | 1996 | 23 | 0.010 |
Why?
|
| Mozambique | 1 | 1996 | 20 | 0.010 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1977 | 93 | 0.010 |
Why?
|
| Fungemia | 1 | 1996 | 22 | 0.010 |
Why?
|
| Rural Health | 1 | 1996 | 50 | 0.010 |
Why?
|
| British Columbia | 1 | 1996 | 8 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1997 | 174 | 0.010 |
Why?
|
| Clinical Trials as Topic | 3 | 1988 | 1100 | 0.010 |
Why?
|
| Nurseries, Hospital | 2 | 1991 | 6 | 0.010 |
Why?
|
| Hypertension | 1 | 2005 | 1329 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1976 | 212 | 0.010 |
Why?
|
| Refugees | 1 | 1996 | 30 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 1983 | 855 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1989 | 249 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1998 | 388 | 0.010 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1995 | 23 | 0.010 |
Why?
|
| Autoanalysis | 1 | 1995 | 8 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 1018 | 0.010 |
Why?
|
| Diarrhea | 1 | 1997 | 317 | 0.010 |
Why?
|
| Colorimetry | 1 | 1995 | 16 | 0.010 |
Why?
|
| Meninges | 1 | 1995 | 18 | 0.010 |
Why?
|
| Mice | 3 | 1996 | 17633 | 0.010 |
Why?
|
| Random Allocation | 2 | 1988 | 441 | 0.010 |
Why?
|
| Diffusion | 1 | 1993 | 57 | 0.010 |
Why?
|
| Triage | 1 | 1995 | 137 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 299 | 0.010 |
Why?
|
| Drug Implants | 1 | 1993 | 42 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1996 | 471 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 344 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1992 | 73 | 0.010 |
Why?
|
| Sheep | 1 | 1993 | 220 | 0.010 |
Why?
|
| Weight Loss | 1 | 1996 | 481 | 0.010 |
Why?
|
| Child Development | 1 | 1995 | 266 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1995 | 684 | 0.010 |
Why?
|
| Cell Movement | 1 | 1995 | 847 | 0.010 |
Why?
|
| Regional Health Planning | 1 | 1991 | 6 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 1065 | 0.010 |
Why?
|
| Intensive Care, Neonatal | 1 | 1991 | 53 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 375 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1990 | 3 | 0.010 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 1990 | 5 | 0.010 |
Why?
|
| Patient Transfer | 1 | 1991 | 105 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1995 | 2397 | 0.010 |
Why?
|
| Maternal Age | 2 | 1980 | 134 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 309 | 0.000 |
Why?
|
| Hemolysin Proteins | 1 | 1988 | 30 | 0.000 |
Why?
|
| Salmonella typhimurium | 1 | 1987 | 43 | 0.000 |
Why?
|
| Penicillinase | 1 | 1987 | 2 | 0.000 |
Why?
|
| Daptomycin | 1 | 1987 | 13 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1992 | 668 | 0.000 |
Why?
|
| Hemolysis | 1 | 1987 | 112 | 0.000 |
Why?
|
| Body Fluids | 1 | 1987 | 47 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1992 | 3056 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1987 | 391 | 0.000 |
Why?
|
| Cochlear Duct | 1 | 1986 | 5 | 0.000 |
Why?
|
| Organ of Corti | 1 | 1986 | 26 | 0.000 |
Why?
|
| Superoxides | 1 | 1985 | 152 | 0.000 |
Why?
|
| Brain | 1 | 1996 | 2998 | 0.000 |
Why?
|
| Complement C5 | 1 | 1984 | 7 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1984 | 70 | 0.000 |
Why?
|
| Complement C5a | 1 | 1984 | 24 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1983 | 7 | 0.000 |
Why?
|
| Adsorption | 1 | 1983 | 32 | 0.000 |
Why?
|
| Peptides | 1 | 1987 | 811 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 108 | 0.000 |
Why?
|
| Developmental Disabilities | 1 | 1988 | 712 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1986 | 470 | 0.000 |
Why?
|
| Drug Antagonism | 1 | 1981 | 12 | 0.000 |
Why?
|
| Klebsiella Infections | 1 | 1982 | 54 | 0.000 |
Why?
|
| Neurosyphilis | 1 | 1981 | 14 | 0.000 |
Why?
|
| Temperature | 1 | 1982 | 307 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1983 | 780 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 443 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1981 | 194 | 0.000 |
Why?
|
| Ear | 1 | 1980 | 25 | 0.000 |
Why?
|
| Biological Assay | 1 | 1981 | 104 | 0.000 |
Why?
|
| Cephalometry | 1 | 1980 | 33 | 0.000 |
Why?
|
| Blood-Brain Barrier | 1 | 1981 | 141 | 0.000 |
Why?
|
| Rectum | 1 | 1980 | 99 | 0.000 |
Why?
|
| Silver Sulfadiazine | 1 | 1979 | 9 | 0.000 |
Why?
|
| Gentian Violet | 1 | 1979 | 8 | 0.000 |
Why?
|
| Soaps | 1 | 1979 | 7 | 0.000 |
Why?
|
| Coloring Agents | 1 | 1979 | 77 | 0.000 |
Why?
|
| Body Height | 1 | 1980 | 215 | 0.000 |
Why?
|
| Enterotoxemia | 1 | 1977 | 1 | 0.000 |
Why?
|
| Diarrhea, Infantile | 1 | 1977 | 35 | 0.000 |
Why?
|
| Disease Reservoirs | 1 | 1977 | 35 | 0.000 |
Why?
|
| Personnel, Hospital | 1 | 1977 | 34 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1981 | 1697 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1980 | 871 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1980 | 1324 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 1983 | 1527 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1980 | 514 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1983 | 880 | 0.000 |
Why?
|
| Feces | 1 | 1977 | 727 | 0.000 |
Why?
|